Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone

Transfusion

Volumn 38, Issue 8, 1998, Pages 713-721

  Dale, D C ^a   Liles, W C ^a   Llewellyn, C ^a   Rodger, E ^a   Price, T H ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CELL MIGRATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; MALE; NEUTROPHIL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031874080     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38898375509.x     Document Type: Article

References (48)

1. Strauss RG. Clinical perspectives of granulocyte transfusions: efficacy to date. J Clin Apheresis 1995;10:114-8.
2. Schiffer CA. Granulocyte transfusions: an overlooked therapeutic modality. Transfus Med Rev 1990;4:2-7.
3. Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972;287:367-71.
4. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974;44:571-81.
5. Higby DJ, Mishler JM, Rhomberg W, et al. The effect of a single or double dose of dexamethasone on granulocyte collection with the continuous flow centrifuge. Vox Sang 1975;28:243-8.
6. Boggs DR. Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia. N Engl J Med 1974;290:1055-62.
7. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81:1675-8.
8. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis 1996;11:1-9.
9. Dale DC, Liles WC, Summer WR, Nelson S. Granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis 1995;172:1061-75.
10. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996;88:335-40.
11. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor (rhG-CSF) on the neutrophil response and peripheral blood colony forming cells in healthy young and elderly volunteers. Blood 1994;84:2923-9.
12. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
13. Casper CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
14. Hester JP, Dignani MC, Anaissie E, et al. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 1995;10:188-93.
15. Leitman SF, Yu M, Lekstrom J. Pair-controlled study of granulocyte colony stimulating factor (G-CSF) plus dexamethasone (Dexa) for granulocytapheresis donors (abstract). Transfusion 1995;35:53s.
16. Liles WC, Huang JE, Llewellyn C, et al. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal human volunteers. Transfusion 1997;37:182-7.
17. Dale DC, Liles WC, Llewellyn C, Price TH. The effects of granulocyte macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers. Am J Hematol 1998;57:7-15.
18. Kiener PA, Davis PM, Rankin BM,et al. Human monocytic cells contain high levels of intracellular Fas ligand - rapid release following cellular activation. J Immunol 1997;159:1594-8.
19. Klebanoff SJ, Olszowski S, Van Voorhis WC, et al. Effects of gamma-interferon on human neutrophils: protection from deterioration on storage. Blood 1992;80:225-34.
20. Klebanoff SJ, Waltersdorph AM, Rosen H. Antimicrobial activity of myeloperoxidase. Methods Enzymol 1984;105:399-403.
21. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method donor corticosteroid treatment and short term storage. Blood 1979;54:977-86.
22. Athens JW, Haab OP, Raab SO, et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 1961;40:989-95.
23. 32P-diisopropyl fluorophosphate for neutrophil kinetic studies. Acta Haematol 1982;67:175-9.
24. Ohsaka A, Kitigawa S, Sakamoto S, et al. In vivo activation of human PMN functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989;74:2743-8.
25. Yuo A, Kitigawa S, Ohsaka A, et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses tiggered by receptor-mediated agonists and stimulation of C3bi receptor exxpression and adherence. Blood 1989;74:2144-9.
26. Itoh Y, Kuratsuji T, Tsunawaki S, et al. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal PMN function and membrane effector molecule expression. Int J Hematol 1991;54:463-9.
27. Repp R, Valerius T, Sendler A, et al. PMN express the high affinity receptor for IgG (FcγRI; CD64) after in vivo application of rhG-CSF. Blood 1991;78:885-9.
28. Yong KL, Linch DC. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on PMN adhesion in vitro and in vivo. Eur J Haematol 1992;49:251-9.
29. Kerst JM, van de Winkel JG, Evans AH, et al. Granulocyte colony-stimulating factor induces hFcγRI (CD64 antigen)-positive PMN via an effect on myeloid precursor cells. Blood 1993;81:1457-64.
30. Kerst JM, de Haas M, van der Schoot CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophentypically and functionally altered PMN via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
31. Ohsaka A, Saijoni K, Sato N, et al. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human PMN in vitro and in vivo. Br J Haematol 1993;84:574-80.
32. Hansen PB, Kjaersgaard E, Johnsen HE, et al. Different membrane expression of CD11b and CD14 on blood PMN following in vivo administration of myeloid growth factors. Br J Haematol 1993;85:50-6.
33. Valerius T, Repp R, de Wit TP, et al. Involvement of the high-affinity receptor for IgG (FcγRI; CD64) in enhanced tumor cell cytotoxicity of PMN during granulocyte colony-stimulating factor therapy. Blood 1993;82:931-9.
34. Nathan CF. Respiratory burst in adherent human PMN: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989;73:301-6.
35. Sullivan GW, Carper HT, Mandell GL. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 1993;81:1863-70.
36. Balazovich KJ, Almeida HI, Boxer LA. Recombinant human G-CSF and GM-CSF prime human PMN for superoxide production through different signal transduction mechanisms. J Lab Clin Med 1991;118:576-84.
37. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976;58:705-15.
38. Filep JG, Delalandre A, Payette Y, Foldes-Filep E. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 1997;96:295-301.
39. Liles WC, Rodger ER, Dale DC. Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18, and L-selectin following the administration of G-CSF in vivo and in vitro. Clin Res 1994;42:237a.
40. Hakansson L, Hoglund M, Jonsson UB, et al. Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Br J Haematol 1997;98:603-11.
41. Phillips TR, Yang WC, Schultz RD. The effects of glucocorticosteroids on the chemiluminescence response of bovine phagocytic cells. Vet Immunol Immunopathol 1987;14:245-56.
42. Liles WC, Huang JE, van Burik JH, et al. Granulocyte colony-stimulating factor (G-CSF) administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012-5.
43. Colotta F, Re F, Polentaruffi N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
44. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor: role and relationships in infectious diseases. J Infect Dis 1995;172:1061-75.
45. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-8.
46. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils-separation of survival and activation outcomes. J Immunol 1995;154:4719-25.
47. Bowden R, Price T, Boeckh M, et al. Phase I/II study of granulocyte transfusions from G - CSF-stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients (abstract). Blood 1997;90(Suppl 1):435a.
48. Price TH, Bowden RA, Boeckh M, et al. Neutrophil collection from community apheresis donors after granulocyte colony-stimulating factor and dexamethasone stimulation: feasibility and efficacy (abstract). Blood 1997;90(Suppl 1):137b.